| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 608 | 2018 |
| Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy VLJL Thijssen, R Postel, RJ Brandwijk, RPM Dings, I Nesmelova, S Satijn, ... Proceedings of the National Academy of Sciences 103 (43), 15975-15980, 2006 | 592 | 2006 |
| Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization RPM Dings, M Loren, H Heun, E McNiel, AW Griffioen, KH Mayo, ... Clinical Cancer Research 13 (11), 3395-3402, 2007 | 343 | 2007 |
| Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells CW Song, H Lee, RPM Dings, B Williams, J Powers, TD Santos, BH Choi, ... Scientific reports 2 (1), 362, 2012 | 330 | 2012 |
| Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature JR Van Beijnum, RP Dings, E Van Der Linden, BMM Zwaans, ... Blood 108 (7), 2339-2348, 2006 | 311 | 2006 |
| Anti‐angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte‐endothelium interactions and infiltration in tumors AEM Dirkx, MGA Egbrink, K Castermans, DWJ Van Der Schaft, ... The FASEB Journal 20 (6), 621-630, 2006 | 281 | 2006 |
| Epigenetic regulation of tumor endothelial cell anergy: silencing of intercellular adhesion molecule-1 by histone modifications DMEI Hellebrekers, K Castermans, E Viré, RPM Dings, NTH Hoebers, ... Cancer research 66 (22), 10770-10777, 2006 | 168 | 2006 |
| Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding RPM Dings, MC Miller, I Nesmelova, L Astorgues-Xerri, N Kumar, ... Journal of medicinal chemistry 55 (11), 5121-5129, 2012 | 146 | 2012 |
| Galectins as molecular targets for therapeutic intervention RPM Dings, MC Miller, RJ Griffin, KH Mayo International journal of molecular sciences 19 (3), 905, 2018 | 136 | 2018 |
| Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities RPM Dings, X Chen, DMEI Hellebrekers, LI Van Eijk, Y Zhang, TR Hoye, ... Journal of the National Cancer Institute 98 (13), 932-936, 2006 | 127 | 2006 |
| The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin RPM Dings, Y Yokoyama, S Ramakrishnan, AW Griffioen, KH Mayo Cancer research 63 (2), 382-385, 2003 | 127 | 2003 |
| The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models DWJ van der Schaft, RPM Dings, QG de Lussanet, LI van Eijk, AW Nap, ... The FASEB journal 16 (14), 1991-1993, 2002 | 114 | 2002 |
| Angiogenesis gene expression profiling in xenograft models to study cellular interactions VLJL Thijssen, RJ Brandwijk, RPM Dings, AW Griffioen Experimental cell research 299 (2), 286-293, 2004 | 106 | 2004 |
| Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice G Boysen, A Jamshidi-Parsian, MA Davis, ER Siegel, CM Simecka, ... International journal of radiation biology 95 (4), 436-442, 2019 | 103 | 2019 |
| Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells RPM Dings, BW Williams, CW Song, AW Griffioen, KH Mayo, RJ Griffin International journal of cancer 115 (2), 312-319, 2005 | 98 | 2005 |
| Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors RJ Griffin, RPM Dings, A Jamshidi-Parsian, CW Song International Journal of Hyperthermia 26 (3), 256-263, 2010 | 95 | 2010 |
| Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells RA Kore, JL Edmondson, SV Jenkins, A Jamshidi-Parsian, RPM Dings, ... Biochemistry and biophysics reports 14, 104-113, 2018 | 92 | 2018 |
| Enhancement of T-cell–mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer RPM Dings, KB Vang, K Castermans, F Popescu, Y Zhang, ... Clinical Cancer Research 17 (10), 3134-3145, 2011 | 83 | 2011 |
| Anti-tumor activity of the novel angiogenesis inhibitor anginex RPM Dings, DWJ Van Der Schaft, B Hargittai, J Haseman, AW Griffioen, ... Cancer letters 194 (1), 55-66, 2003 | 81 | 2003 |
| Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activity KH Mayo, RPM Dings, C Flader, I Nesmelova, B Hargittai, ... Journal of Biological Chemistry 278 (46), 45746-45752, 2003 | 80 | 2003 |